Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 1846 AL 1860

Versatile nanomaterials for Alzheimer's disease: Pathogenesis inspired disease-modifying therapy

Xi Y, Chen Y, Jin Y, Han G, Song M, Song T, Shi Y, Tao L, Huang Z, Zhou J, Ding Y, Zhang H.

J Control Release. 2022 May;345:38-61. doi: 10.1016/j.jconrel.2022.02.034. Epub 2022 Mar 4.

Role of HSV-1 in Alzheimer's disease pathogenesis: A challenge for novel preventive/therapeutic strategies

Protto V, Marcocci ME, Miteva MT, Piacentini R, Li Puma DD, Grassi C, Palamara AT, De Chiara G.

Curr Opin Pharmacol. 2022 Apr;63:102200. doi: 10.1016/j.coph.2022.102200. Epub 2022 Mar 8.

[Causal treatment of Alzheimer's disease: amyloid antibodies]

Pawlowski M, Warnecke T.

Inn Med (Heidelb). 2022 Sep;63(9):1000-1008. doi: 10.1007/s00108-022-01291-2. Epub 2022 Mar 15.

Analysis of treatment pattern of anti-dementia medications in newly diagnosed Alzheimer's dementia using OMOP CDM

Byun J, Lee DY, Jeong CW, Kim Y, Rhee HY, Moon KW, Heo J, Hong Y, Kim WJ, Nam SJ, Choi HS, Park JI, Chun IK, Bak SH, Lee K, Byeon GH, Kim KL, Kim JA, Park YJ, Kim JH, Lee EJ, Lee SA, Kwon SO, Park SW, Kasani PH, Kim JK, Kim Y, Kim S, Jang JW.

Sci Rep. 2022 Mar 15;12(1):4451. doi: 10.1038/s41598-022-08595-1.

Microglial activation in Alzheimer's disease: The role of flavonoids and microRNAs

Medrano-Jiménez E, Meza-Sosa KF, Urbán-Aragón JA, Secundino I, Pedraza-Alva G, Pérez-Martínez L.

J Leukoc Biol. 2022 Jul;112(1):47-77. doi: 10.1002/JLB.3MR1021-531R. Epub 2022 Mar 16.

Enhancing autophagy in Alzheimer's disease through drug repositioning

Eshraghi M, Ahmadi M, Afshar S, Lorzadeh S, Adlimoghaddam A, Rezvani Jalal N, West R, Dastghaib S, Igder S, Torshizi SRN, Mahmoodzadeh A, Mokarram P, Madrakian T, Albensi BC, Łos MJ, Ghavami S, Pecic S.

Pharmacol Ther. 2022 Sep;237:108171. doi: 10.1016/j.pharmthera.2022.108171. Epub 2022 Mar 16.

Effects of Supplementation with Probiotics in Experimental Models of Alzheimer's Disease: A Systematic Review of Animal Experiments

Neta FI, de Souza FES, Batista AL, Pinheiro FI, Cobucci RN, Guzen FP.

Curr Alzheimer Res. 2022;19(3):188-201. doi: 10.2174/1567205019666220318092003.

Structural Modifications on Chalcone Framework for Developing New Class of Cholinesterase Inhibitors

George G, Koyiparambath VP, Sukumaran S, Nair AS, Pappachan LK, Al-Sehemi AG, Kim H, Mathew B.

Int J Mol Sci. 2022 Mar 14;23(6):3121. doi: 10.3390/ijms23063121.

Sovateltide Mediated Endothelin B Receptors Agonism and Curbing Neurological Disorders

Ranjan AK, Gulati A.

Int J Mol Sci. 2022 Mar 15;23(6):3146. doi: 10.3390/ijms23063146.

Copper-mediated β-amyloid toxicity and its chelation therapy in Alzheimer's disease

Singh SK, Balendra V, Obaid AA, Esposto J, Tikhonova MA, Gautam NK, Poeggeler B.

Metallomics. 2022 Jun 13;14(6):mfac018. doi: 10.1093/mtomcs/mfac018.

Role of Cholinergic Signaling in Alzheimer's Disease

Chen ZR, Huang JB, Yang SL, Hong FF.

Molecules. 2022 Mar 10;27(6):1816. doi: 10.3390/molecules27061816.

Effects of multisite anodal transcranial direct current stimulation combined with cognitive stimulation in patients with Alzheimer's disease and its neurophysiological correlates: A double-blind randomized clinical trial

Andrade SM, Machado DGDS, Silva-Sauerc LD, Regis CT, Mendes CKTT, de Araújo JSS, de Araújo KDT, Costa LP, Queiroz MEBS, Leitão MM, Fernández-Calvo B.

Neurophysiol Clin. 2022 Apr;52(2):117-127. doi: 10.1016/j.neucli.2022.02.003. Epub 2022 Mar 24.

Alzheimer's Disease: Key Insights from Two Decades of Clinical Trial Failures

Kim CK, Lee YR, Ong L, Gold M, Kalali A, Sarkar J.

J Alzheimers Dis. 2022;87(1):83-100. doi: 10.3233/JAD-215699.

Pharmacological Exploration of Triazole-based Therapeutics for Alzheimer's Disease: An Overview

Prasanna CAL, Sharma A.

Curr Drug Targets. 2022;23(9):933-953. doi: 10.2174/1389450123666220328153741.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias